4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-15-027035
CIK 0001328143operating
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:27 PM ET
Size
8.3 KB
Accession
0001209191-15-027035
Insider Transaction Report
Form 4
BOOTH RICHARD H
Director
Transactions
- Sale
Common Stock
2015-03-16$17.36/sh−1,000$17,360→ 48,778 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:27 PM ET
- Size
- 8.3 KB